The development and production of mRNA therapeutics and vaccines requires expertise in both chemical synthesis and microbial fermentation. […] […]
Leveraging Existing Technologies with New Dedicated Facilities for mRNA Projects

The development and production of mRNA therapeutics and vaccines requires expertise in both chemical synthesis and microbial fermentation. […] […]
BIOVECTRA’s Scott Doncaster, Neil Morrison, and Cameron Graham discuss the company’s addition of single-use fermenter technology […] […]
Much of the innovation occurring in the pharmaceutical industry today is achieved by smaller pharma/biotech firms with limited commercial manufacturing experience […] […]
The production of increasingly complex small molecule APIs is challenging drug makers. CDMOs with multiple capabilities are needed to develop efficient routes to synthesize these […] […]